Home›Companies›Biotech & Pharma›StimuSIL

StimuSIL, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 7, 2025·Suggest an edit

About StimuSIL

StimuSIL is a private company based in Wilmington, Delaware, incorporated in 2021 in Delaware. It has reported $2,327,572 raised in four offerings on Form D since August 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 31, 2024Mar 7, 2025$599,988fully sold2$299KEquityRule 506(b)Form D ↗
Apr 8, 2024May 10, 2024$1,103,787fully sold7$157KEquityRule 506(b)Form D ↗
Aug 31, 2023Sep 13, 2023$48,799fully sold1$48,799EquityRule 506(b)Form D ↗
Jul 1, 2022Aug 12, 2022amended Aug 30, 2022$574,998fully sold12$47,917EquityRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$2,327,572

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on StimuSIL's Form D filed Mar 7, 2025.

AG
AV
Ana Villalba Villar
Executive officer and director
PV
Pablo Villalba
Executive officer and director

Earlier filings also listed Firat Yerlikaya (director, last listed May 2024).

Sources

  1. SECStimuSIL, Inc. Form D, filed Aug 12, 2022
  2. SECStimuSIL, Inc. filing history